[Immunotherapy for malignant pleural mesothelioma]

Tidsskr Nor Laegeforen. 2021 Sep 6;141. doi: 10.4045/tidsskr.21.0503. Print 2021 Sep 7.
[Article in Norwegian]
No abstract available

MeSH terms

  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Mesothelioma, Malignant*

Substances

  • Immunologic Factors